David Lu is a partner in the firm's Intellectual Property practice. David focuses his practice on patent prosecution, strategic intellectual property counseling, and due diligence for life science industries. He has designed global patent strategies in the field of pharmaceuticals and biotechnology, and managed large patent portfolios for a variety of clients. David's clients range from international corporations, mid-sized biotech companies, to venture capital funded startups.
David has handled matters in numerous technology areas, including cancer therapies, genome technologies, gene therapies, antibodies and antibody-drug conjugates, mRNA technologies, siRNA drugs, personalized medicine, small molecules, diagnostic methods, medical devices, and laboratory instruments. By identifying each client's technology strengths and business goals, David provides customized and creative legal solutions.
